跳至主要内容
临床试验/NCT02251509
NCT02251509Unknown4 期

Rate Control in Atrial Fibrillation: A Randomized, Double-Blind, Crossover Comparison of Carvedilol and Metoprolol Tartrate

Creighton University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
20
试验地点
1
主要终点
Resting heart rate

研究概览

简要总结

This study will evaluate the efficacy of metoprolol tartrate compared to carvedilol on heart rate control in patients with atrial fibrillation and a rapid ventricular rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Permanent atrial fibrillation
  • Baseline ventricular rate (prior to treatment) > 110 bpm

排除标准

  • History of accessory tract re-entry tachycardia
  • Ejection fraction < 35% or history of NYHA Class III/IV stage C/D heart failure
  • Acute coronary syndrome, percutaneous coronary intervention, or cardiac surgery in the past 2 months
  • Child-Pugh class B or C hepatic dysfunction
  • Uncontrolled hypertension
  • Thyroid disease
  • Intolerance to beta-blockers
  • History of lung disease resulting in hospitalization in the past year

研究组 & 干预措施

Carvedilol

Experimental

carvedilol BID for 2 weeks

干预措施: Carvedilol (Drug)

Metoprolol tartrate

Experimental

Metoprolol tartrate BID for 2 weeks

干预措施: Metoprolol tartrate (Drug)

结局指标

主要结局

Resting heart rate

时间窗: 2 weeks

Resting heart rate less than 80 bpm

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验